Early Access Program Results From Turkey and a Literature Review on

• Main Authors: Beksac, M, Aydin, Y, Goker, H, Turgut, M, Besisik, SK, Cagirgan, S, Tuglular, T, Vural, F, Yagci, M, Alacacioglu, I, Aytan, P, Goksoy, HS, Gulbas, Z, Gunes, AK, Gurkan, E, Hacioglu, SK, Karti, SS, Kaynar, L, Ozdogu, H, Paydas, S, Solmaz, S, Sonmez, M, Tekgunduz, E, Yildirim, R, Ilhan, O
• Format: Review
• Language: English
• Published: CIG MEDIA GROUP, LP 2020
• Subjects: EAP; Efficacy; RRMM; Safety; Survival; Ege; sami
• Online Access: http://hdl.handle.net/11499/38104

The present study investigated the efficacy and safety profile of daratumumab monotherapy in 42 patients with relapsed refractory multiple myeloma through a Turkish early access program. The current findings have confirmed the efficacy of daratumumab monotherapy in heavily pretreated patients with r...